BRIGHT HEALTH GROUP INC (BHG)
US10920V4041 - Common Stock
Taking everything into account, BHG scores 2 out of 10 in our fundamental rating. BHG was compared to 117 industry peers in the Health Care Providers & Services industry. BHG has a bad profitability rating. Also its financial health evaluation is rather negative. BHG is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year BHG has reported negative net income.
BHG had a negative operating cash flow in the past year.
In the past 5 years BHG always reported negative net income.
In multiple years BHG reported negative operating cash flow during the last 5 years.
1.2 Ratios
BHG has a worse Return On Assets (-79.71%) than 90.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -79.71% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-26.23%
ROA(5y)N/A
ROE(3y)-110.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BHG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
BHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
BHG has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, BHG has a worse debt to assets ratio.
2.2 Solvency
BHG has an Altman-Z score of -1.98. This is a bad value and indicates that BHG is not financially healthy and even has some risk of bankruptcy.
BHG's Altman-Z score of -1.98 is on the low side compared to the rest of the industry. BHG is outperformed by 81.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.98 |
ROIC/WACCN/A
WACC6.5%
2.3 Liquidity
A Current Ratio of 1.09 indicates that BHG should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.09, BHG is doing worse than 66.09% of the companies in the same industry.
BHG has a Quick Ratio of 1.09. This is a normal value and indicates that BHG is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BHG (1.09) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
BHG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.41%, which is quite impressive.
Looking at the last year, BHG shows a very strong growth in Revenue. The Revenue has grown by 367.50%.
Measured over the past years, BHG shows a very strong growth in Revenue. The Revenue has been growing by 104.82% on average per year.
EPS 1Y (TTM)47.41%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q78.68%
Revenue 1Y (TTM)367.5%
Revenue growth 3Y104.82%
Revenue growth 5YN/A
Revenue growth Q2Q39.3%
3.2 Future
The Earnings Per Share is expected to grow by 24.13% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -15.72% on average over the next years. This is quite bad
EPS Next Y25.96%
EPS Next 2Y38.14%
EPS Next 3Y24.13%
EPS Next 5YN/A
Revenue Next Year-45.23%
Revenue Next 2Y-27.55%
Revenue Next 3Y-15.72%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BHG. In the last year negative earnings were reported.
Also next year BHG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
BHG's earnings are expected to grow with 24.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.14%
EPS Next 3Y24.13%
5. Dividend
5.1 Amount
BHG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BRIGHT HEALTH GROUP INC
NYSE:BHG (1/26/2024, 7:04:13 PM)
16.35
+1.4 (+9.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap130.47M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -79.71% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)47.41%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y25.96%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)367.5%
Revenue growth 3Y104.82%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y